Description

ARA-290 8mg is the mid-range format of this non-haematopoietic EPO analogue studied for neuropathic pain reduction, anti-inflammatory activity via IRR activation, and tissue protection. The 8mg vial offers a practical research size between entry and larger formats. Nexopep supplies independently tested and lyophilised. For research use only.

Reviews

There are no reviews yet.

Be the first to review “ARA-290 8mg”

Your email address will not be published. Required fields are marked *